The efficiency and adverse events of radiotherapy with cetuximab for Japanese head and neck cancer patients
Author:
Publisher
Elsevier BV
Subject
General Medicine,Otorhinolaryngology,Surgery
Reference27 articles.
1. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer;Forastiere;N Engl J Med,2003
2. Antiemetic therapy of fosaprepitant, palonosetron, and dexamethasone combined with cisplatin-based chemotherapy for head and neck carcinomas;Tsukahara;Acta Otolaryngol,2014
3. Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck;Bonner;N Engl J Med,2006
4. Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck;Okano;Jpn J Clin Oncol,2013
5. Roles of chemotherapy in head and neck cancer;Tsukahara;Practica OtoRhinolaryngol,2016
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The use of cetuximab for oral cancer and adverse events with different treatment regimens: A single‐center retrospective study over an 11‐year period;Oral Science International;2024-06-09
2. Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo;Cancers;2023-12-03
3. Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study;PLOS ONE;2022-07-28
4. Drug-induced interstitial lung disease in recurrent and/or metastatic head and neck cancer patients treated with cetuximab and/or nivolumab;Oral Oncology;2021-02
5. Predicting the efficacy of chemoradiotherapy for locally advanced human papilloma virus-related oropharyngeal squamous cell carcinoma using one course of TPF chemotherapy;European Archives of Oto-Rhino-Laryngology;2021-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3